ישראל - עברית - Ministry of Health

עמוס גזית בע"מ - רופא

ישראל - עברית - Ministry of Health

דרורת בע"מ - כלל האוכלוסיה - ליין של תכשירים לשימוש וגינלי -טיפול אינטימי טבעי

ישראל - עברית - Ministry of Health

neopharm cure (2005) ltd - midazolam as hydrochloride 2.5 mg - oromucosal solution - midazolam - treatment of prolonged, acute, convulsive seizures in infants, toddlers, children and adolescents (from 3 months to < 18 years). buccolam must only be used by parents/carers where the patient has been diagnosed to have epilepsy. for infants between 3-6 months of age treatment should be in a hospital setting where monitoring is possible and resuscitation equipment is available.

ישראל - עברית - Ministry of Health

neopharm cure (2005) ltd - midazolam as hydrochloride 5 mg - oromucosal solution - midazolam - treatment of prolonged, acute, convulsive seizures in infants, toddlers, children and adolescents (from 3 months to < 18 years). buccolam must only be used by parents/carers where the patient has been diagnosed to have epilepsy. for infants between 3-6 months of age treatment should be in a hospital setting where monitoring is possible and resuscitation equipment is available.

ישראל - עברית - Ministry of Health

neopharm cure (2005) ltd - midazolam as hydrochloride 7.5 mg - oromucosal solution - midazolam - treatment of prolonged, acute, convulsive seizures in infants, toddlers, children and adolescents (from 3 months to < 18 years). buccolam must only be used by parents/carers where the patient has been diagnosed to have epilepsy. for infants between 3-6 months of age treatment should be in a hospital setting where monitoring is possible and resuscitation equipment is available.

ישראל - עברית - Ministry of Health

neopharm cure (2005) ltd - midazolam as hydrochloride 10 mg - oromucosal solution - midazolam - treatment of prolonged, acute, convulsive seizures in infants, toddlers, children and adolescents (from 3 months to < 18 years). buccolam must only be used by parents/carers where the patient has been diagnosed to have epilepsy. for infants between 3-6 months of age treatment should be in a hospital setting where monitoring is possible and resuscitation equipment is available

ישראל - עברית - Ministry of Health

given imaging ltd - רופא - the pillcam platform with a pillcam sb capsule is intended for visualization of the small bowel mucosa including assessment for severity and extent of small bowel abnormalities. it may be used as a tool in the detection, diagnosis and surveillance of abnormalities and conditions of the small bowel such as: • inflammatory bowel diseases including crohn’s disease, colitis, indeterminate colitis and ileitis • obscure bleeding (ogib) and iron deficiency anemia (ida) • tumors of the small bowel including benign and malignant types and polyposis syndromes (fap and pjs) • malabsorption abnormalities including celiac disease and motility issues relating to ibs it may be used in the detection of small bowel mucosal damage as defined in the capsule endoscopy standardized terminology (cest) to include: • excavated lesions such as ulcers, aphtha ulcers, erosions, scars and diverticulum • erythematous mucosa • edematous mucosa • flat lesions such as red spots, plaque, angioectasia • protruding lesions such as nodules, pol

ישראל - עברית - Ministry of Health

zoetis israel holding b.v., israel - moxidectin; praziquantel - ג'ל - moxidectin 1.95 %w/w; praziquantel 12.17 %w/w - equest pramox veterinary is indicated for treatment of mixed cestodes and nematodes or arthropods infections, caused by moxidectin and praziquantel sensitive strains of : large strongyles, small strongyles (adults and intraluminal larval stages), ascarids and other species, tapeworm (adults). the egg reappearance period of small strongyles is 90 days. the product is effective against (developing) intramucosal l4 stages of small strongyles. at 8 weeks after treatment, early (hypobiotic) el3 stages of small strongyles are eliminated.

ישראל - עברית - Ministry of Health

perrigo israel agencies ltd - כלל האוכלוסיה - gives relief of pain via mechanical barrier action by a protective film that forms in situ and adheres to the oromucosal surface. intended use of episil® includes oral mucositis that may be caused by chemotherapy or radiotherapy

ישראל - עברית - Ministry of Health

כמיפל בע"מ - כלל האוכלוסיה - otrimer is used to daily cleanse the nasal cavities and helps to eliminate excess mucus produced during colds and allergic conditions. the product is also indicated for moisturizing the nasal mucosa when suffering from irritation and / or dryness.